<DOC>
	<DOCNO>NCT00783042</DOCNO>
	<brief_summary>The aim study investigate whether non-invasive ultrasound method assessment coronary blood flow , transthoracic Doppler echocardiography-coronary flow reserve ( TTDE-CFR ) , used measure drug effect .</brief_summary>
	<brief_title>Exploratory Study Coronary Flow Reserve Measurements , Non-Invasive Method Coronary Function Measurements</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Males age 4575 year females aged 6075 year inclusive Carotid and/or femoral atherosclerotic plaque , assess carotid ultrasound examination within last 5 year Abnormal concentration lipids lipoprotein blood Provision sign informed consent Treatment statins lipidlowering drug , e.g . fibrates , nicotinic acid , cholesterol absorption inhibitor , within last 6 month randomisation Current smoking snuff tobacco use Major CV event ( myocardial infarction ( MI ) , stroke/ transitory ischemic attack ( TIA ) , Acute Coronary Syndrome ( ACS ) , revascularisation ) within last 6 month randomisation Symptomatic carotid stenosis , atrioventricular ( AV ) block , QTprolongation , atrial fibrillation , sinus node disease ( sick sinus syndrome symptomatic bradycardia ) , chronic obstructive pulmonary disease ( COPD ) asthma</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>TTDE-CFR</keyword>
	<keyword>coronary artery function</keyword>
	<keyword>cardiovascular biomarkers</keyword>
	<keyword>rosuvastatin</keyword>
	<keyword>Crestor</keyword>
</DOC>